Vifor Clinches Deal For Travere's Rare Kidney Disorder Drug

Pays $55m Upfront For Sparsentan

 
• By Kevin Grogan
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.

More from Genitourinary

More from Therapeutic Category